Market closedADR

GENFIT/$GNFT

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About GENFIT

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Ticker

$GNFT

Sector

Health Care

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Loos, France

Employees

169

Website

www.genfit.com

GENFIT Metrics

BasicAdvanced

$170M

7.68 $0.45

1.09 -

Price and volume

Market cap

$170M

Beta

1.09

52-week high

$6.24

52-week low

$3.31

Average daily volume

6.6K

Financial strength

Current ratio

3.744

Quick ratio

3.642

Long term debt to equity

61.405

Total debt to equity

69.64

Interest coverage (TTM)

4.31%

Management effectiveness

Return on assets (TTM)

6.51%

Return on equity (TTM)

25.91%

Valuation

Price to earnings (TTM)

7.682

Price to revenue (TTM)

2.072

Price to book

1.7

Price to tangible book (TTM)

3.29

Price to free cash flow (TTM)

-3.899

Growth

Revenue change (TTM)

175.45%

Earnings per share change (TTM)

-163.31%

3-year revenue growth (CAGR)

136.69%

3-year earnings per share growth (CAGR)

-22.81%

What the Analysts think about GENFIT

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for GENFIT stock.

GENFIT Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

GENFIT Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

GENFIT News

AllArticlesVideos

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

GlobeNewsWire·1 day ago

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

GlobeNewsWire·2 months ago

GENFIT Reports Third Quarter 2024 Financial Information

GlobeNewsWire·2 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $GNFT

$

Capital at risk

Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for GENFIT stock?

GENFIT (GNFT) has a market cap of $170M as of January 15, 2025.

What is the P/E ratio for GENFIT stock?

The price to earnings (P/E) ratio for GENFIT (GNFT) stock is 7.68 as of January 15, 2025.

Does GENFIT stock pay dividends?

No, GENFIT (GNFT) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next GENFIT dividend payment date?

GENFIT (GNFT) stock does not pay dividends to its shareholders.

What is the beta indicator for GENFIT?

GENFIT (GNFT) has a beta rating of 1.09. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.